QR Kodea

Oncolytic Rhabdovirus Vaccine Boosts Chimeric Anti-DEC205 Priming for Effective Cancer Immunotherapy

Prime-boost vaccination employing heterologous viral vectors encoding an antigen is an effective strategy to maximize the antigen-specific immune response. Replication-deficient adenovirus serotype 5 (Ad5) is currently being evaluated clinically in North America as a prime in conjunction with oncoly...

Deskribapen osoa

Gorde:
Egile Nagusiak: Fanny Tzelepis, Harsimrat Kaur Birdi, Anna Jirovec, Silvia Boscardin, Christiano Tanese de Souza, Mohsen Hooshyar, Andrew Chen, Keara Sutherland, Robin J. Parks, Joel Werier, Jean-Simon Diallo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier 2020-12-01
Saila:Molecular Therapy: Oncolytics
Gaiak:
anti-DEC205
rhabdovirus
oncolytic vaccine
Ad5
prime-boost
immunotherapy
Sarrera elektronikoa:http://www.sciencedirect.com/science/article/pii/S2372770520301583
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak